{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:31:54Z","timestamp":1792099914783,"version":"4.4.0"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:title>Lay Summary<\/jats:title>\n                  <jats:p>Alopecia areata (AA) is a long-term condition that can occur in both children and adults. AA can appear as patches of baldness on the scalp. Sometimes, nail growth is also affected. Hair on other parts of the body may also fall out, such as the beard, eyebrows and eyelashes.<\/jats:p>\n                  <jats:p>Alopecia totalis is the name for total loss of scalp hair. Alopecia universalis is complete loss of scalp, facial and body hair.<\/jats:p>\n                  <jats:p>This is the second version of the guideline. The British Association of Dermatologists gathered a group of experts in managing people of all ages with AA. The group consisted of eight consultant dermatologists, one dermatology specialist registrar, one general practitioner, one psychologist, two people with AA and a team with expertise in preparing guidelines. This group of experts reviewed relevant studies published until 11 July 2025. Using the evidence, the group produced recommendations using rigorous standards for guideline development.<\/jats:p>\n                  <jats:p>The guideline development group produced 56 recommendations for management of people with AA. They also made 9 recommendations for future research and suggested 11 audit points for hospitals.<\/jats:p>\n                  <jats:p>Based on the guideline, a patient information leaflet is also available on the British Association of Dermatologists\u2019 website (https:\/\/www.skinhealthinfo.org.uk\/condition\/alopecia-areata).<\/jats:p>","DOI":"10.1093\/bjd\/ljaf452","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:56:45Z","timestamp":1763038605000},"page":"e56-e73","source":"Crossref","is-referenced-by-count":6,"title":["British Association of Dermatologists living guideline for managing people with alopecia areata 2025"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0563-8690","authenticated-orcid":false,"given":"Matthew J","family":"Harries","sequence":"first","affiliation":[{"name":"Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre , Manchester ,","place":["UK"]},{"name":"Centre for Dermatology Research, Faculty of Biology, Medicine and Health, University of Manchester & NIHR Biomedical Research Centre , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Royal London Hospital, Barts Health NHS Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9426-1898","authenticated-orcid":false,"given":"Anna","family":"Ascott","sequence":"additional","affiliation":[{"name":"University Hospitals Sussex NHS Foundation Trust , Sussex ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Bhatti","sequence":"additional","affiliation":[{"name":"Mid Yorkshire Teaching NHS Trust , Wakefield ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Earley","sequence":"additional","affiliation":[{"name":"Patient representative"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9695-0884","authenticated-orcid":false,"given":"Paul","family":"Farrant","sequence":"additional","affiliation":[{"name":"University Hospitals Sussex NHS Foundation Trust , Sussex ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-2653","authenticated-orcid":false,"given":"Susan","family":"Holmes","sequence":"additional","affiliation":[{"name":"NHS Greater Glasgow and Clyde , Glasgow ,","place":["UK"]},{"name":"University of Glasgow , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Johnson","sequence":"additional","affiliation":[{"name":"Patient representative"},{"name":"Alopecia UK , Shipley ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-5113","authenticated-orcid":false,"given":"Abby E","family":"Macbeth","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospitals NHS Trust , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1424-8069","authenticated-orcid":false,"given":"Andrew G","family":"Messenger","sequence":"additional","affiliation":[{"name":"University of Sheffield , Sheffield ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0505-2913","authenticated-orcid":false,"given":"Julian","family":"Pearce","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0329-3205","authenticated-orcid":false,"given":"Anita","family":"Takwale","sequence":"additional","affiliation":[{"name":"Gloucestershire Hospitals NHS Foundation Trust , Gloucester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6788-7222","authenticated-orcid":false,"given":"Andrew R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Cardiff & The Vale University Health Board and School of Psychology, University of Cardiff , Cardiff ,","place":["UK"]},{"name":"British Psychological Society , Leicester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-5351","authenticated-orcid":false,"given":"Maria","family":"Hashme","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists , Willan House, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4070-0696","authenticated-orcid":false,"given":"M Firouz","family":"Mohd Mustapa","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists , Willan House, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1983-2010","authenticated-orcid":false,"given":"Alina M","family":"Constantin","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists , Willan House, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"2026012706475256300_ljaf452-B1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bjd\/ljae385","article-title":"British Association of Dermatologists living guideline for managing people with alopecia areata 2024","volume":"192","author":"Harries","year":"2025","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bjd.15201","article-title":"Updated guidance for writing a British Association of Dermatologists clinical guideline: the adoption of the GRADE methodology 2016","volume":"176","author":"Mohd Mustapa","year":"2017","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B3","author":"Australian Living Evidence Consortium"},{"key":"2026012706475256300_ljaf452-B4","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"key":"2026012706475256300_ljaf452-B5","author":"The GRADE Working Group"},{"key":"2026012706475256300_ljaf452-B6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2026012706475256300_ljaf452-B7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2021.08.043","article-title":"Development of the alopecia areata scale for clinical use: results of an academic\u2013industry collaborative effort","volume":"86","author":"King","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/bjd.20644","article-title":"A retrospective study evaluating the outcomes of high-dose methylprednisolone pulse therapy for 483 patients with moderate-to-severe alopecia areata","volume":"185","author":"Wada-Irimada","year":"2021","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B9","author":"Institute of Medical Illustrators. National standards and guides to best practice"},{"key":"2026012706475256300_ljaf452-B10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","article-title":"A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population","volume":"122","author":"L\u00f6we","year":"2010","journal-title":"J Affect Disord"},{"key":"2026012706475256300_ljaf452-B11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"2026012706475256300_ljaf452-B12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1054-139X(01)00333-0","article-title":"The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients","volume":"30","author":"Johnson","year":"2002","journal-title":"J Adolesc Health"},{"key":"2026012706475256300_ljaf452-B13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026012706475256300_ljaf452-B14","first-page":"237","article-title":"Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents","volume":"5","author":"Angold","year":"1995","journal-title":"Int J Methods Psychiatr Res"},{"key":"2026012706475256300_ljaf452-B15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) \u2013 a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"2026012706475256300_ljaf452-B16","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jisp.2017.10.009","article-title":"The utility and validity of the Alopecia Areata Symptom Impact Scale in measuring disease-related symptoms and their effect on functioning","volume":"19","author":"Mendoza","year":"2018","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2026012706475256300_ljaf452-B17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13555-021-00648-z","article-title":"Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) questionnaire in adults and adolescents with alopecia areata","volume":"12","author":"Wyrwich","year":"2022","journal-title":"Dermatol Ther"},{"key":"2026012706475256300_ljaf452-B18","author":"Alopecia"},{"key":"2026012706475256300_ljaf452-B19"},{"key":"2026012706475256300_ljaf452-B20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/bjd\/ljad253","article-title":"When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials","volume":"189","author":"King","year":"2023","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B21"},{"key":"2026012706475256300_ljaf452-B22"},{"key":"2026012706475256300_ljaf452-B23","author":"US Food and Drug Administration"},{"key":"2026012706475256300_ljaf452-B24"},{"key":"2026012706475256300_ljaf452-B25"},{"key":"2026012706475256300_ljaf452-B26"},{"key":"2026012706475256300_ljaf452-B27"},{"key":"2026012706475256300_ljaf452-B28","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists\u2019 guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/bjd.20628","article-title":"The epidemiology of alopecia areata: a population-based cohort study in UK primary care","volume":"186","author":"Harries","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000254503","article-title":"A new classification of alopecia areata","volume":"131","author":"Ikeda","year":"1965","journal-title":"Dermatologica"},{"key":"2026012706475256300_ljaf452-B31","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/jid.1950.52","article-title":"A statistical study and consideration of endocrine influences","volume":"14","author":"Walker","year":"1950","journal-title":"J Invest Dermatol"},{"key":"2026012706475256300_ljaf452-B33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2340\/0001555549180188","article-title":"Alopecia areata. A follow-up investigation of outpatient material","volume":"49","author":"Gip","year":"1969","journal-title":"Acta Derm Venereol"},{"key":"2026012706475256300_ljaf452-B34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jdv.15994","article-title":"Alopecia totalis and universalis long-term outcomes: a review","volume":"34","author":"Burroway","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026012706475256300_ljaf452-B35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000066435","article-title":"Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis","volume":"205","author":"Sato-Kawamura","year":"2002","journal-title":"Dermatology"},{"key":"2026012706475256300_ljaf452-B36","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jisp.2020.04.002","article-title":"The evolving pathogenesis of alopecia areata: major open questions","volume":"20","author":"Paus","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2026012706475256300_ljaf452-B37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jaad.2009.10.032","article-title":"Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"key":"2026012706475256300_ljaf452-B39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0733-8635(05)70392-2","article-title":"The pathogenesis of alopecia areata","volume":"14","author":"McDonagh","year":"1996","journal-title":"Dermatol Clin"},{"key":"2026012706475256300_ljaf452-B40","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"key":"2026012706475256300_ljaf452-B41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/JID.2015.402","article-title":"Functional interpretation of genome-wide association study evidence in alopecia areata","volume":"136","author":"Petukhova","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2026012706475256300_ljaf452-B42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/exd.13123","article-title":"Genomewide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2","volume":"26","author":"Fischer","year":"2017","journal-title":"Exp Dermatol"},{"key":"2026012706475256300_ljaf452-B43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/bjd.16808","article-title":"Alopecia areata: a review of disease pathogenesis","volume":"179","author":"Rajabi","year":"2018","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2004.09.014","article-title":"A \u2018hairy\u2019 privilege","volume":"26","author":"Paus","year":"2005","journal-title":"Trends Immunol"},{"key":"2026012706475256300_ljaf452-B45","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/jidsymp.2013.7","article-title":"The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives","volume":"16","author":"Paus","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2026012706475256300_ljaf452-B46","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"key":"2026012706475256300_ljaf452-B47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2133.2005.06453.x","article-title":"Interferon-\u03b3 is a potent inducer of catagen-like changes in cultured human anagen hair follicles","volume":"152","author":"Ito","year":"2005","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-4632.2004.02028.x","article-title":"The role of psychological factors in alopecia areata and the impact of the disease on the quality of life","volume":"43","author":"Gulec","year":"2004","journal-title":"Int J Dermatol"},{"key":"2026012706475256300_ljaf452-B49","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2008.371","article-title":"Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H\/HeJ mouse model","volume":"129","author":"Zhang","year":"2009","journal-title":"J Invest Dermatol"},{"key":"2026012706475256300_ljaf452-B50","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2353\/ajpath.2007.061206","article-title":"Probing the effects of stress mediators on the human hair follicle: substance P holds central position","volume":"171","author":"Peters","year":"2007","journal-title":"Am J Pathol"},{"key":"2026012706475256300_ljaf452-B51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2008.02.005","article-title":"Onset of alopecia areata after Epstein\u2013Barr virus infectious mononucleosis","volume":"59","author":"Rodriguez","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B52","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.clindermatol.2016.07.004","article-title":"Nutrition and skin: kids are not just little people","volume":"34","author":"McCusker","year":"2016","journal-title":"Clin Dermatol"},{"key":"2026012706475256300_ljaf452-B53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/bjd.12980","article-title":"Vitamin D deficiency in alopecia areata","volume":"170","author":"Aksu Cerman","year":"2014","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"2026012706475256300_ljaf452-B55","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.14309\/crj.2017.107","article-title":"Hair growth in two alopecia patients after fecal microbiota transplant","volume":"4","author":"Rebello","year":"2017","journal-title":"ACG Case Rep J"},{"key":"2026012706475256300_ljaf452-B56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ced\/llac104","article-title":"Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study","volume":"48","author":"Holmes","year":"2023","journal-title":"Clin Exp Dermatol"},{"key":"2026012706475256300_ljaf452-B57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaad.2010.08.032","article-title":"Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study","volume":"65","author":"Chu","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B58","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5021\/ad.2014.26.6.722","article-title":"Differences in comorbidity profiles between early-onset and late-onset alopecia areata patients: a retrospective study of 871 Korean patients","volume":"26","author":"Lee","year":"2014","journal-title":"Ann Dermatol"},{"key":"2026012706475256300_ljaf452-B59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/bjd.21055","article-title":"The associated burden of mental health conditions in alopecia areata: a population-based study in UK primary care","volume":"187","author":"Macbeth","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jamadermatol.2018.4398","article-title":"Assessment of a bidirectional association between major depressive disorder and alopecia areata","volume":"155","author":"Vallerand","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2026012706475256300_ljaf452-B61","first-page":"130","article-title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity","volume":"182","author":"Bain","year":"2020","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B62","first-page":"1357","article-title":"Stigmatization caused by hair loss \u2013 a systematic literature review","volume":"18","author":"Schielein","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026012706475256300_ljaf452-B63","doi-asserted-by":"crossref","first-page":"11718","DOI":"10.1038\/srep11718","article-title":"Alopecia areata increases the risk of stroke: a 3-year follow-up study","volume":"5","author":"Kang","year":"2015","journal-title":"Sci Rep"},{"key":"2026012706475256300_ljaf452-B64","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/jamadermatol.2020.1133","article-title":"Time-dependent risk of acute myocardial infarction in patients with alopecia areata in Korea","volume":"156","author":"Shin","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2026012706475256300_ljaf452-B65","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2340\/00015555-2964","article-title":"Alopecia areata is associated with increased expression of heart disease biomarker cardiac troponin I","volume":"98","author":"Wang","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"2026012706475256300_ljaf452-B66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaad.2016.02.1234","article-title":"Cardiovascular risk in patients with alopecia areata (AA): a propensity-matched retrospective analysis","volume":"75","author":"Huang","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B67","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamadermatol.2019.0629","article-title":"All-cause and cause-specific mortality risks associated with alopecia areata: a Korean nationwide population-based study","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2026012706475256300_ljaf452-B68","volume-title":"Rook\u2019s Textbook of Dermatology","author":"Harries","year":"2024","edition":"10 edn"},{"key":"2026012706475256300_ljaf452-B69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2340\/00015555-0466","article-title":"Atrichia with papular lesions: a report of three novel human hairless gene mutations and a revision of diagnostic criteria","volume":"88","author":"Yip","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"2026012706475256300_ljaf452-B70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2020.03.004","article-title":"The Alopecia Areata Consensus of Experts (ACE) study: results of an international expert opinion on treatments for alopecia areata","volume":"83","author":"Meah","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B71","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archderm.1963.01590210048007","article-title":"Alopecia areata. An evaluation of 736 patients","volume":"88","author":"Muller","year":"1963","journal-title":"Arch Dermatol"},{"key":"2026012706475256300_ljaf452-B72","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaad.2018.10.066","article-title":"Screening of thyroid function and autoantibodies in patients with alopecia areata: a systematic review and meta-analysis","volume":"80","author":"Lee","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B73","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s40257-023-00805-4","article-title":"Comorbid conditions associated with alopecia areata: a systematic review and meta-analysis","volume":"24","author":"Ly","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"2026012706475256300_ljaf452-B74","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/1346-8138.14940","article-title":"Chronological association between alopecia areata and autoimmune thyroid diseases: a systematic review and meta-analysis","volume":"46","author":"Kinoshita-Ise","year":"2019","journal-title":"J Dermatol"},{"key":"2026012706475256300_ljaf452-B75","doi-asserted-by":"crossref","first-page":"656","DOI":"10.15537\/smj.2016.6.13777","article-title":"Severe subtype of alopecia areata is highly associated with thyroid autoimmunity","volume":"37","author":"Bin Saif","year":"2016","journal-title":"Saudi Med J"},{"key":"2026012706475256300_ljaf452-B76","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/1346-8138.14648","article-title":"Alopecia areata and overt thyroid diseases: a nationwide population-based study","volume":"45","author":"Han","year":"2018","journal-title":"J Dermatol"},{"key":"2026012706475256300_ljaf452-B77","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamadermatol.2017.3694","article-title":"Screening guidelines for thyroid function in children with alopecia areata","volume":"153","author":"Patel","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2026012706475256300_ljaf452-B78","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2133.1994.tb02917.x","article-title":"A study of the tissue iron status of patients with alopecia areata","volume":"130","author":"White","year":"1994","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B79","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2133.1995.tb08727.x","article-title":"Iron status of patients with alopecia areata","volume":"132","author":"Boffa","year":"1995","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5070\/D33681B2MM","article-title":"Evaluation of serum iron and ferritin levels in alopecia areata","volume":"14","author":"Esfandiarpour","year":"2008","journal-title":"Dermatol Online J"},{"key":"2026012706475256300_ljaf452-B81","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/1346-8138.13705","article-title":"Changes of serum trace elements level in patients with alopecia areata: a meta-analysis","volume":"44","author":"Jin","year":"2017","journal-title":"J Dermatol"},{"key":"2026012706475256300_ljaf452-B82","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4161\/derm.24411","article-title":"Reduced level of 25-hydroxyvitamin D in chronic\/relapsing alopecia areata","volume":"5","author":"d\u2019Ovidio","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"2026012706475256300_ljaf452-B83","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00403-016-1687-y","article-title":"Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women","volume":"308","author":"Thompson","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"2026012706475256300_ljaf452-B84","first-page":"440","article-title":"Alopecia areata investigational assessment guidelines \u2013 part II","volume":"51","author":"Olsen","year":"2004","journal-title":"National Alopecia Areata Foundation. J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B85","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa2110343","article-title":"Two phase 3 trials of baricitinib for alopecia areata","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012706475256300_ljaf452-B86","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/bjd.18883","article-title":"The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials","volume":"183","author":"Wyrwich","year":"2020","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B87","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/bjd.19024","article-title":"Development of the Scalp Hair Assessment PRO\u2122 measure for alopecia areata","volume":"183","author":"Wyrwich","year":"2020","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B88","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40257-020-00545-9","article-title":"Development of clinician-reported outcome (ClinRO) and patient-reported outcome (PRO) measures for eyebrow, eyelash and nail assessment in alopecia areata","volume":"21","author":"Wyrwich","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"2026012706475256300_ljaf452-B89","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamadermatol.2023.5869","article-title":"The Alopecia Areata Severity and Morbidity Index (ASAMI) study: results from a global expert consensus exercise on determinants of alopecia areata severity","volume":"160","author":"Moussa","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2026012706475256300_ljaf452-B90","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bjd\/ljac050","article-title":"Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper","volume":"188","author":"McSweeney","year":"2023","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B91","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjd.21696","article-title":"Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes","volume":"187","author":"Renert-Yuval","year":"2022","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B92"},{"key":"2026012706475256300_ljaf452-B93","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jaad.2023.03.041","article-title":"Switching between tofacitinib and baricitinib in alopecia areata: a review of clinical response","volume":"89","author":"Kazmi","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B94","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/jamadermatol.2022.6687","article-title":"Efficacy of methotrexate alone versus methotrexate plus low-dose prednisone in patients with alopecia areata totalis or universalis: a 2-step double-blind randomized clinical trial","volume":"159","author":"Joly","year":"2023","journal-title":"JAMA Dermatol"},{"key":"2026012706475256300_ljaf452-B95","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jaad.2019.04.053","article-title":"Cyclosporine for moderate-to-severe alopecia areata: a double-blind, randomized, placebo-controlled clinical trial of efficacy and safety","volume":"81","author":"Lai","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B96","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaad.2019.08.080","article-title":"Combination tofacitinib and oral minoxidil treatment for severe alopecia areata","volume":"85","author":"Wambier","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2026012706475256300_ljaf452-B97","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archderm.1992.01680210045005","article-title":"Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata","volume":"128","author":"Olsen","year":"1992","journal-title":"Arch Dermatol"},{"key":"2026012706475256300_ljaf452-B98","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.8.4.527","article-title":"Production of congenital defects in the off-spring of pregnant mice treated with cortisone; progress report","volume":"8","author":"Fraser","year":"1951","journal-title":"Pediatrics"},{"key":"2026012706475256300_ljaf452-B99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1242\/dev.5.2.201","article-title":"The embryology of cortisone-induced cleft palate","volume":"5","author":"Walker","year":"1957","journal-title":"Development"},{"key":"2026012706475256300_ljaf452-B100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/bjd\/ljad193","article-title":"British Society for Paediatric and Adolescent Dermatology assessment and support of mental health in children and young people with skin conditions: a multidisciplinary expert consensus statement and recommendations","volume":"189","author":"McPherson","year":"2023","journal-title":"Br J Dermatol"},{"key":"2026012706475256300_ljaf452-B101","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5021\/ad.2013.25.4.471","article-title":"Early intervention with high-dose steroid pulse therapy prolongs disease-free interval of severe alopecia areata: a retrospective study","volume":"25","author":"Yang","year":"2013","journal-title":"Ann Dermatol"},{"key":"2026012706475256300_ljaf452-B102","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/ced\/llaf055","article-title":"The Global Register of Alopecia areata disease Severity and treatment Safety \u2013 UK (GRASS-UK): importance of real-world data in alopecia areata","volume":"50","author":"Harries","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2026012706475256300_ljaf452-B103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2020.5839","article-title":"A global eDelphi exercise to identify core domains and domain items for the development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)","volume":"157","author":"Wall","year":"2021","journal-title":"JAMA Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf452\/65288050\/ljaf452.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/e56\/65288050\/ljaf452.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/2\/e56\/65288050\/ljaf452.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:48:10Z","timestamp":1769514490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/2\/e56\/8322888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":103,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,14]]},"published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf452","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,14]]}}}